Corvidia Therapeutics:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Corvidia Therapeutics - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C2809
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Corvidia Therapeutics is a developer of cardiovascular therapies. The company develops cardiovascular therapies leveraging functional genomics. Its pipeline programs are targeted at identifying patients with unique sensitivity to specific biologic pathways, which allows the development of therapies targeting those pathways. Corvidia Therapeutics’ pathways confer unique concepts within the field of cardiovascular medicines and an unprecedented accelerated path-to-market. The company’s development programs include random genetic mutations, nature conduct experiments and subtly changing process. It operates through collaborations with various distinguished scientists and drug developers. Corvidia Therapeutics is headquartered in Waltham, Massachusetts, the US.

Corvidia Therapeutics – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Corvidia Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Corvidia Therapeutics, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Corvidia Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Corvidia Therapeutics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Corvidia Therapeutics, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Corvidia Therapeutics, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Corvidia Therapeutics Raises USD60 Million in Series B Venture Financing 10
Corvidia Therapeutics Raises USD26 Million in Series A Financing 12
Licensing Agreements 13
Corvidia Therapeutics Enters into Licensing Agreement with AstraZeneca 13
Corvidia Therapeutics – Key Competitors 14
Corvidia Therapeutics – Key Employees 15
Corvidia Therapeutics – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Corporate Communications 17
Mar 29, 2018: Corvidia Therapeutics Appoints Marc de Garidel as Chief Executive Officer 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Corvidia Therapeutics, Pharmaceuticals & Healthcare, Key Facts 2
Corvidia Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Corvidia Therapeutics, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Corvidia Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Corvidia Therapeutics, Deals By Therapy Area, 2012 to YTD 2018 8
Corvidia Therapeutics, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Corvidia Therapeutics Raises USD60 Million in Series B Venture Financing 10
Corvidia Therapeutics Raises USD26 Million in Series A Financing 12
Corvidia Therapeutics Enters into Licensing Agreement with AstraZeneca 13
Corvidia Therapeutics, Key Competitors 14
Corvidia Therapeutics, Key Employees 15

List of Figures
Corvidia Therapeutics, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Corvidia Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Corvidia Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Corvidia Therapeutics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Corvidia Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Corvidia Therapeutics, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Corvidia Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Corvidia Therapeutics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Corvidia Therapeutics:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Patel Engineering Ltd:企業の戦略・SWOT・財務分析
    Patel Engineering Ltd - Strategy, SWOT and Corporate Finance Report Summary Patel Engineering Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Australian Agricultural Company Limited:企業の戦略・SWOT・財務分析
    Australian Agricultural Company Limited - Strategy, SWOT and Corporate Finance Report Summary Australian Agricultural Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Vaxart Inc (VXRT):企業の財務・戦略的SWOT分析
    Vaxart Inc (VXRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Richter Gedeon Nyrt (RICHTER):企業の財務・戦略的SWOT分析
    Richter Gedeon Nyrt (RICHTER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Perceptron Inc (PRCP):企業の財務・戦略的SWOT分析
    Summary Perceptron Inc (Perceptron) is a technology company that produces, develops, and markets automated industrial metrology products and solutions. The company’s products include dimensional inspection, robot guidance, dimensional gauging, gap and flush solutions, 3D scanning, and metrology soft …
  • Coastal Contacts Inc:医療機器:M&Aディール及び事業提携情報
    Summary Coastal Contacts Inc (Coastal Contacts), a subsidiary of Essilor International Compagnie Generale d'Optique SA, is an online retailer that markets eye care products. The company provides products such as eyeglasses, contact lenses, sunglasses and vision care accessories, among others. It off …
  • Canadian Pacific Railway Limited (CP):企業の財務・戦略的SWOT分析
    Canadian Pacific Railway Limited (CP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Energia Argentina SA:電力:M&Aディール及び事業提携情報
    Summary Energia Argentina SA (ENARSA) is a state owned energy company that explores and exploits hydrocarbons in solid, liquid and gaseous states. It stores, transports, distributes, markets and industrializes the hydrocarbons and their derivatives. Energia conducts design, construction, commissioni …
  • Companhia de Saneamento Basico do Estado de Sao Paulo (SBSP3):企業の財務・戦略的SWOT分析
    Summary Companhia de Saneamento Basico do Estado de Sao Paulo (SABESP) is an environmental consulting company that is responsible for supplying water and collecting and treating sewage in municipalities of Sao Paulo state. The company provides water and sewage services in another four municipalities …
  • Sensorion SA (ALSEN):企業の財務・戦略的SWOT分析
    Summary Sensorion SA (Sensorion) is a biopharmaceutical company that develops therapies. The company provides treatments for vestibular and cochlear pathologies. It develops drug candidates through its technology platform for the treatment of various therapeutic areas including vestibular neuritis, …
  • Jacobs Engineering Group Inc.:企業の戦略・SWOT・財務情報
    Jacobs Engineering Group Inc. - Strategy, SWOT and Corporate Finance Report Summary Jacobs Engineering Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • HL Global Enterprises Limited:企業の戦略・SWOT・財務情報
    HL Global Enterprises Limited - Strategy, SWOT and Corporate Finance Report Summary HL Global Enterprises Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • CES Energy Solutions Corp (CEU):企業の財務・戦略的SWOT分析
    CES Energy Solutions Corp (CEU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Obsidian Energy Ltd (OBE):石油・ガス:M&Aディール及び事業提携情報
    Summary Obsidian Energy Ltd (Obsidian) is formerly known as Penn West Petroleum Ltd. It is a conventional oil and natural gas production and development company in Canada with a well-balanced portfolio of high-quality assets. It develops and explores oil and gas properties and related production inf …
  • Bank Of Ningbo Co. Ltd.:企業の戦略・SWOT・財務分析
    Bank Of Ningbo Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Bank Of Ningbo Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Diagnostics For All Inc:企業の製品パイプライン分析2018
    Summary Diagnostics For All Inc (DFA) is a drug development company that develops and commercializes of new technology and practical diagnostic devices for diagnostic companies. The company uses patterned paper technology to create electrochemical clinical chemistry assays, immunoassays, assays, and …
  • Herman Miller Inc (MLHR):企業の財務・戦略的SWOT分析
    Herman Miller Inc (MLHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • FMC Corp (FMC):企業の財務・戦略的SWOT分析
    FMC Corp (FMC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Borregaard ASA (BRG):企業の財務・戦略的SWOT分析
    Borregaard ASA (BRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • ABB, Ltd.:企業の戦略・SWOT・財務情報
    ABB, Ltd. - Strategy, SWOT and Corporate Finance Report Summary ABB, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆